An international, randomized, placebo‐controlled, phase 2b clinical trial of intepirdine for dementia with Lewy bodies (HEADWAY‐DLB)-Reference-Cited by-同舟云学术

An international, randomized, placebo‐controlled, phase 2b clinical trial of intepirdine for dementia with Lewy bodies (HEADWAY‐DLB)

Published:2021-01 Issue:1 Volume:7 Page:
ISSN:2352-8737
Container-title:Alzheimer's & Dementia: Translational Research & Clinical Interventions
language:en
Short-container-title:A&D Transl Res & Clin Interv

Author:

Lang Frederick M.¹²,Kwon Daniel Y.¹²,Aarsland Dag³⁴,Boeve Brad⁵,Tousi Babak⁶,Harnett Mark¹,Mo Yi¹,Noel Sabbagh Marwan⁷

Affiliation:

1. Axovant Sciences New York New York USA

2. Roivant Sciences Inc. (Roivant) New York New York USA

3. Centre for Age‐Related Medicine (SESAM) Stavanger University Hospital Stavanger Norway

4. Institute of Psychiatry Psychology and Neuroscience King's College London London UK

5. Department of Neurology Mayo Clinic Rochester Minnesota USA

6. Cleveland Clinic Lou Ruvo Center for Brain Health Cleveland Ohio USA

7. Department of Neurology University of Nevada (NLV) and Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas Nevada USA

Publisher

Wiley

Subject

Psychiatry and Mental health,Neurology (clinical)

Link

Reference41 articles.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献